Last edition
News about "Aurobindo Pharma Manufacturing Facility"
FDA Issues 11 Observations to Aurobindo Pharma Manufacturing Facility
Aurobindo Pharma has reported that its formulation manufacturing facility in Telangana received 11 procedural observations from the United States Food and Drug Administration (FDA) after a routine inspection.
Aurobindo Pharma Manufacturing Facility | 09/02/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members